MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
STRO Balance Sheet Sankey DiagramSankey diagram visualizing STRO balance sheet for the periodMarketable securities$110,011K (-22.04%↓ Y/Y)Cash and cashequivalents$54,335K (-15.13%↓ Y/Y)Accounts receivable$5,797K (-27.53%↓ Y/Y)Prepaid expenses andother current assets$5,504K (-70.25%↓ Y/Y)Total current assets$175,647K (-24.17%↓ Y/Y)Operating leaseright-of-use assets$8,467K (-42.93%↓ Y/Y)Property and equipment,net$8,357K (-44.22%↓ Y/Y)Other non-currentassets$1,133K (2166.00%↑ Y/Y)Restricted cash$858K (0.00%↑ Y/Y)Total assets$194,462K (-25.88%↓ Y/Y)Accumulated deficit-$1,054,972K (-20.66%↓ Y/Y)Accumulated othercomprehensive (loss) income-$58K (-346.15%↓ Y/Y)Total liabilities andstockholders' deficit$194,462K (-25.88%↓ Y/Y)Total stockholders'deficit-$103,317K (-221.75%↓ Y/Y)Additionalpaid-in-capital$951,696K (13.01%↑ Y/Y)Common stock, 0.001 parvalue - 300,000,000...$17K (-80.00%↓ Y/Y)Total liabilities$297,779K (1.13%↑ Y/Y)Deferred royaltyobligation related to the...$239,064K (19.48%↑ Y/Y)Total currentliabilities$52,898K (-28.75%↓ Y/Y)Operating lease liability- non-current$4,123K (-64.26%↓ Y/Y)Other non-currentliabilities$1,694K (0.00%↑ Y/Y)Accrued expenses andother current...$30,241K (-20.74%↓ Y/Y)Operating lease liability- current$6,660K (-17.34%↓ Y/Y)Deferred revenue -current$6,456K (-46.04%↓ Y/Y)Accrued compensation$6,185K (-47.42%↓ Y/Y)Accounts payable$3,356K (-22.10%↓ Y/Y)

SUTRO BIOPHARMA, INC. (STRO)

SUTRO BIOPHARMA, INC. (STRO)

Balance Sheet
Quarterly Balance Sheet for the quarter ending in 2026-06-30
source: myfinsight.com